Theophylline-down, but not out: Part II

Hospital Pharmacy

Volumn 31, Issue 3, 1996, Pages 298-317

  Burnakis, Thomas G ^a  

^a BAPTIST MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; METHOTREXATE; THEOPHYLLINE;

DRUG INDICATION; HUMAN; HYPOTENSION; NEPHROTOXICITY; NEUROTOXICITY; SHORT SURVEY; SYNCOPE; VASODILATATION;

EID: 0029979553     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Belardinelii L, Linden J, Berne RM. The cardiac effects of adcnosine. Prog Cardiovasc Dis 1989; 32:73-97.
2. Nelson SD, Stanley M, Love CJ, Coyne KS, Schaal SF. The autonomie and hemodynamic effects of oral theophylline in patients with vasodepressor syncope. Arch Intern Med 1991; 151:2425-29.
3. Sra JS, Jazayeri MR, Avitall B, et al. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole. N Engl J Med 1993, 328:1085-90.
4. Bernini JC, Fort DW, Griener JC, Kane BJ, Chappell WB, Kamen B. Aminophylline for methotrexate-induced neurotoxicity. Lancet 1995; 345:544-47.
5. Arend LJ, Bakris GL, Burnett JCJ, Megenan C, Spielman WS. Role for intrarenal adenosine in the renal hemodynamic response to contrast media. J Lab Clin Med 1987; 110:406-11.
6. Erley CM, Duda SH, Schlepckow S, et al. Adenosine antagonist theophylline prevents the reduction of giomerular filtration rate after contrast media application. Kidney Int 1994; 45:1425-31.
7. Hedqvist P, Fredholm B, Olundh S. Antagonistic effects of theophylline and adenosine on adrenergic neuroeffector transmission in the rabbit kidney. Circ Res 1978; 43:592-98.